Reassessing Th1 versus Th17.1 in sarcoidosis: new tricks for old dogma

Edward S. Chen

Source: Eur Respir J, 51 (3) 1800010; 10.1183/13993003.00010-2018
Journal Issue: March

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Edward S. Chen. Reassessing Th1 versus Th17.1 in sarcoidosis: new tricks for old dogma. Eur Respir J, 51 (3) 1800010; 10.1183/13993003.00010-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017


The pathogenesis of IPF: what is the latest paradigm?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019

Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers
Source: Eur Respir J 2005; 25: 397-399
Year: 2005


Specific antigen(s) in sarcoidosis: a link to autoimmunity?
Source: Eur Respir J 2016; 47: 707-709
Year: 2016


What's new in sarcoidosis management?
Source: Annual Congress 2013 –ME5 What's new in sarcoidosis management?
Year: 2013



“Management of the patient with eosinophilic asthma: a new era begins”
Source: ERJ Open Res 2016: 00024-2015
Year: 2016



A new piece in the puzzle: the eosinophil and the development of COPD
Source: Eur Respir J, 58 (4) 2101105; 10.1183/13993003.01105-2021
Year: 2021



Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era?
Source: Eur Respir J 2014; 43: 1233-1236
Year: 2014


The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017



Which CD8+ T-cells in asthma? Attacking or defending?
Source: Eur Respir J 2016; 48: 287-290
Year: 2016


Bronchiectasis: new therapies and perspectives
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018


Late Breaking Abstract: A role for IL-25 as ‘initiator‘ in Th2 driven inflammation is restricted to IL-5 high Th2 patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

Bronchiectasis: the new, the old and the ugly
Source: International Congress 2018 – State of the art session: Respiratory infections
Year: 2018


Early diagnosis of COPD: myth or a true perspective
Source: Eur Respir Rev, 29 (158) 200131; 10.1183/16000617.0131-2020
Year: 2020



Th17 cell paradox in sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017